CUSIP: 74365AAB7
What is CUSIP 74365AAB7?
CUSIP 74365AAB7 identifies 74365AAB7 - PROTALIX BIOTHERAPEUTICS INC - NOTE 4.500% 9/1 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 74365AAB7:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2018 Q3 | $0 | $0 | -$2,375,000 | 0 | |
| 2018 Q2 | $2,500,000 | $2,375,000 | -$2,592,000 | 95.0% | 1 |
| 2018 Q1 | $5,923,000 | $4,717,000 | +$16,000 | 80.36% | 2 |
| 2017 Q4 | $5,923,000 | $4,701,000 | 80.13% | 2 | |
| 2017 Q3 | $5,923,000 | $4,701,000 | -$8,490,000 | 80.13% | 2 |
| 2017 Q2 | $16,758,000 | $12,998,000 | -$79,572 | 77.35% | 4 |
| 2017 Q1 | $16,853,000 | $14,083,000 | +$2,374,000 | 77.89% | 4 |
| 2016 Q4 | $16,853,000 | $9,277,000 | -$39,076,777 | 56.36% | 4 |
| 2016 Q3 | $77,045,000 | $50,405,000 | -$74,102 | 66.76% | 11 |
| 2016 Q2 | $77,175,000 | $52,388,000 | 66.64% | 11 | |
| 2016 Q1 | $68,975,000 | $47,423,000 | 67.76% | 10 | |
| 2015 Q4 | $97,147,000 | $70,385,000 | +$5,346,418 | 69.1% | 12 |
| 2015 Q3 | $72,667,000 | $53,198,000 | -$144,056 | 71.19% | 12 |
| 2015 Q2 | $69,052,000 | $53,223,000 | +$6,863,456 | 76.73% | 12 |
| 2015 Q1 | $60,052,000 | $45,367,000 | -$6,904,000 | 74.64% | 11 |
| 2014 Q4 | $69,052,000 | $53,037,000 | +$47,595,000 | 75.87% | 12 |